Clinical Trial Update: Combination Chemotherapy in Treating Patients With Recurrent or Refractory Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a combination chemotherapy regimen for recurrent or refractory small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED